Troponin T

Chileno Bay Resorts & Residences, Auberge Resorts Collection Ushers in a New Culinary Era, Welcoming Juan Pablo Loza as Director of Culinary Experiences

Retrieved on: 
Tuesday, February 21, 2023

LOS CABOS, Mexico, Feb. 21, 2023 /PRNewswire-PRWeb/ -- Chileno Bay Resorts & Residences, Auberge Resorts Collection, a contemporary oceanfront resort in Los Cabos known for its culinary excellence, today announces the appointment of Juan Pablo Loza as Director of Culinary Experiences. A native of Mexico City, Chef Loza's 20 years of culinary experience has brought him all over the globe—from China to Argentina to Sweden and many places in between—and now to the property's signature, award-winning restaurant, COMAL. Chef Loza will also oversee the resort's various other dining venues YAYA, TnT, and El Molino Coffee Shop, which all celebrate nuanced influences on contemporary Mexican cuisine, and a program of unique epicurean guest experiences.

Key Points: 
  • Chef Loza will also oversee the resort's various other dining venues YAYA , TnT , and El Molino Coffee Shop , which all celebrate nuanced influences on contemporary Mexican cuisine, and a program of unique epicurean guest experiences .
  • "We are thrilled to welcome Chef Loza, who inspires us with his global perspective and infectious passion for sustainability in the kitchen," said Roger Ponce, regional vice president and general manager, Chileno Bay Resorts & Residences, Auberge Resorts Collection.
  • "I am looking forward to sharing our new menu and vision with our guests this summer," said Juan Pablo Loza, Executive Chef, Chileno Bay, Auberge Resorts Collection.
  • Prior to, Chef Loza worked at several of Mexico City's most acclaimed restaurants, including Le Cirque, Ciboulette, and L'Olivier.

HEXO Increases Production of Its Popular Straight Edge Pre-Rolls and Launches Enhanced Inhalation Technology

Retrieved on: 
Wednesday, February 8, 2023

Consumers have reacted positively to the new format and strains, and this expansion supports HEXO’s continued leadership of the Canadian straight edge pre-roll market.

Key Points: 
  • Consumers have reacted positively to the new format and strains, and this expansion supports HEXO’s continued leadership of the Canadian straight edge pre-roll market.
  • “Canadian customers immediately took to our straight edge pre-roll format, and we recognized that to satisfy the growing demand, we’d need to up our production significantly,” said Charlie Bowman, President and CEO of HEXO.
  • Redecan Redees straight edge pre-rolls also now feature a unique inhalation technology, developed through comprehensive consumer research and feedback.
  • HEXO’s Original Stash line will launch its own straight edge pre-rolls, featuring the line’s popular Atomik Sour Haze and Powdered Donuts.

HEXO Launches Five New Cannabis Strains Under Market-Leading Redecan and Original Stash Brands

Retrieved on: 
Monday, January 9, 2023

HEXO Corp. (TSX: HEXO; NASDAQ: HEXO) ("HEXO" or the “Company”), a leading producer of high-quality cannabis products, is pleased to announce the launch of its new TnT Cannabis strains under the Redecan and Original Stash Brands labels across Canada.

Key Points: 
  • HEXO Corp. (TSX: HEXO; NASDAQ: HEXO) ("HEXO" or the “Company”), a leading producer of high-quality cannabis products, is pleased to announce the launch of its new TnT Cannabis strains under the Redecan and Original Stash Brands labels across Canada.
  • The launch includes three new products from HEXO’s popular Redecan line and two new strains under the Original Stash Brand.
  • The new TnT cannabis strains will feature extremely dense buds covered in trichomes:
    Sex Panther (flower), an Indica hybrid strain, has a powerful effervescent cake flavour.
  • “Less than 0.5% of all cannabis strains we evaluated passed HEXO’s internal criteria to be included in Redecan’s new TnT series,” said Rick Redekop, Master Grower at HEXO and Co-Founder of Redecan.

AFFIRM ORIGINALS & PURE FLIX ANNOUNCE: 'LIVE+LOCAL' A NEW COMEDY SERIES STREAMING THIS JULY EXCLUSIVELY ON PURE FLIX STARRING DAVE COULIER & EMILY PENDERGAST

Retrieved on: 
Wednesday, June 15, 2022

SCOTTSDALE, Ariz., June 15, 2022 /PRNewswire/ --AFFIRM Originals and Pure Flix proudly present " Live+Local ," a new comedy series from creator Dan Merchant.

Key Points: 
  • SCOTTSDALE, Ariz., June 15, 2022 /PRNewswire/ --AFFIRM Originals and Pure Flix proudly present " Live+Local ," a new comedy series from creator Dan Merchant.
  • The new show, starring Dave Coulier and Emily Pendergast, will be exclusively available to stream on Pure Flix on July 7.
  • "Live+Local" is a 6-episode series starring Dave Coulier, Emily Pendergast, Pat Cashman and Kendra Ann Sherill.
  • Register to get all the latest news from AFFIRM Films at www.affirmfilmsupdates.com and follow AFFIRM Films on social media at @AFFIRMFilms.

PURE FLIX & AFFIRM ORIGINALS ANNOUNCE 2022 SLATE OF EXCLUSIVE, NEW SERIES & FILMS

Retrieved on: 
Wednesday, March 9, 2022

SCOTTSDALE, Ariz., March 9, 2022 /PRNewswire/ -- A powerful new slate of original movies and series will exclusively premiere on Pure Flix throughout 2022 from AFFIRM Originals, a division of AFFIRM Films, which is in various stages of production on a multitude of projects.

Key Points: 
  • SCOTTSDALE, Ariz., March 9, 2022 /PRNewswire/ -- A powerful new slate of original movies and series will exclusively premiere on Pure Flix throughout 2022 from AFFIRM Originals, a division of AFFIRM Films, which is in various stages of production on a multitude of projects.
  • Pure Flix CEO Michael Scott said, "We couldn't be more excited for the incredible entertainment streaming this year from fantastic studios like our friends and colleagues at AFFIRM Originals."
  • AFFIRM produces, acquires and markets content that inspires, uplifts and entertains audiences around the world focusing on family and faith through its three divisions, AFFIRM Films, AFFIRM Television and AFFIRM Originals.
  • Register to get all the latest news from AFFIRM Films at www.affirmfilmsupdates.com and follow AFFIRM Films on social media at @AFFIRMFilms.

Worldwide Heart Attack Diagnostics Industry to 2026 - Technological Advancements are Driving Growth - ResearchAndMarkets.com

Retrieved on: 
Friday, November 5, 2021

For example, India and China witness millions of deaths every year due to cardiovascular diseases.

Key Points: 
  • For example, India and China witness millions of deaths every year due to cardiovascular diseases.
  • Thus, North America is expected to dominate the overall heart attack diagnostics market over the forecast period (2021 - 2026).
  • While in Canada, deaths due to heart attack and cardiovascular diseases are as low as 189 out of 100,000 (2019), out of which the heart attack deaths are very less.
  • Whereas, in the other part of North America, i.e., Mexico, the death rate due to heart attack and cardiovascular diseases are quite high.

Prevencio Announces Highly Accurate, AI-driven Blood Test with High Sensitivity (hs) Cardiac Troponin for the Diagnosis of Heart Disease

Retrieved on: 
Tuesday, November 19, 2019

Prevencio, Inc. today announces data confirming the high accuracy of its AI-driven, multiple-protein HART CADhs test, a biomarker clinical/proteomic panel inclusive of high sensitivity cardiac troponin for the diagnosis of obstructive Coronary Artery Disease (CAD), also known as heart disease.

Key Points: 
  • Prevencio, Inc. today announces data confirming the high accuracy of its AI-driven, multiple-protein HART CADhs test, a biomarker clinical/proteomic panel inclusive of high sensitivity cardiac troponin for the diagnosis of obstructive Coronary Artery Disease (CAD), also known as heart disease.
  • HART CADhs data from 1,152 patients were presented as Derivation and External Validation of a High Sensitivity Troponin Based Proteomic Model to Predict the Presence of Obstructive Coronary Artery Disease: Value in the Troponin Indeterminant Zone.
  • In this study, HART CADhs test was developed from 636 patient blood samples from MGH.
  • These patients need timely and accurate assessment, and we are hopeful this blood test will help both patients and clinicians.

U.S. FDA Clears Abbott's High Sensitivity Troponin-I Blood Test That Aids Doctors in Diagnosing Heart Attacks Faster and More Accurately

Retrieved on: 
Wednesday, September 25, 2019

When people enter the emergency room with a suspected heart attack, doctors typically use a troponin blood test to help aid in their diagnosis.

Key Points: 
  • When people enter the emergency room with a suspected heart attack, doctors typically use a troponin blood test to help aid in their diagnosis.
  • Troponin-I proteins are released from the heart and can be found at elevated levels in the blood when the heart muscle has been damaged.
  • Abbott's High Sensitivity Troponin-I blood test measures very low levels of troponin, allowing doctors to evaluate heart attack in patients within two to four hours of admission.
  • "Our research using this high sensitivity assay has demonstrated it can provide doctors with the ability to detect or rule out a heart attack earlier.